Drawing for AMERICA'S BIOPHARMACEUTICAL COMPANIES

USPTO serial 87347024

AMERICA'S BIOPHARMACEUTICAL COMPANIES

Reviewed by CopyMark Law Group

Reg. 6329053Status 700Renewal
Filing date
Status date
Registration date
Apr 20, 2021
Examiner
AWRICH, ELLEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AMERICA'S BIOPHARMACEUTICAL COMPANIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

B. Brett Heavner

B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP901 New York Avenue NWWashington, DC 20001United States

Goods and services

ClassDescriptionStatusFirst use
009Electronic downloadable publications in the nature of fact sheets, reports, and infographics regarding biopharmaceuticals and the biopharmaceutical industryACTIVE—
035Association services, namely, promoting the interests of research-based prescription drug manufacturersACTIVE—
041Providing a website featuring non-downloadable publications in the nature of testimonials, infographics, fact sheets, reports, articles, and videos regarding biopharmaceuticals and the biopharmaceutical industryACTIVE—
042Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research; providing online information in the field of biopharmaceuticals and biopharmaceutical industry regarding biopharmaceutical safety in the nature of biopharmaceutical testingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 20, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 7, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 7, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 7, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 7, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 7, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 20, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 16, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 15, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2021CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 4, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2021CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 19, 2021IUAFUSE AMENDMENT FILED—
Feb 19, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 9, 2020EX5GSOU EXTENSION 5 GRANTED—
Aug 9, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 22, 2020EXT5SOU EXTENSION 5 FILED—
Jul 22, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 13, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 11, 2020EX4GSOU EXTENSION 4 GRANTED—
Feb 11, 2020EXT4SOU EXTENSION 4 FILED—
Feb 11, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 20, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 16, 2019EX3GSOU EXTENSION 3 GRANTED—
Aug 16, 2019EXT3SOU EXTENSION 3 FILED—
Aug 16, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 7, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 5, 2019EX2GSOU EXTENSION 2 GRANTED—
Feb 5, 2019EXT2SOU EXTENSION 2 FILED—
Feb 5, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 13, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 11, 2018EX1GSOU EXTENSION 1 GRANTED—
Jul 11, 2018EXT1SOU EXTENSION 1 FILED—
Jul 11, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 20, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 26, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 26, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 6, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 15, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 13, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 13, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 23, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 23, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 18, 2017DOCKASSIGNED TO EXAMINER—
Mar 3, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 2, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance